Results 1 to 10 of about 61,873 (283)

Urinary NT-proBNP compared head-to-head to plasmatic NT-proBNP in a real life collective with an ICD [PDF]

Indian Pacing and Electrophysiology Journal
Aims: Plasma NT-proBNP is an established marker of heart failure. Previous studies suggested urinary NT-proBNP has potential as marker of chronic heart failure as well. The objective of this study was to compare urinary NT-proBNP to plasma NT-proBNP in a
Benedikt Seither, Alexander Schober, Raphael Allgaier, Christine Meindl, Michael Paulus, Ute Hubauer, Andreas Schober, Ekrem Ücer, Sabine Fredersdorf, Petra Lehn, Andreas Keyser, Andreas Luchner, Lars Maier, Stefan Wallner, Carsten Jungbauer   +14 more
doaj   +4 more sources

SPARCL1 and NT‐proBNP as biomarkers of right ventricular‐to‐pulmonary artery uncoupling in pulmonary hypertension [PDF]

ESC Heart Failure
Aims SPARCL1 was recently identified as a biomarker of right ventricular (RV) maladaptation in patients with pulmonary hypertension (PH), and N‐terminal pro‐brain natriuretic protein (NT‐proBNP) is an established biomarker of RV failure in PH.
Oliver Dörr, Stanislav Keranov, Paulina vanWickern, Holger Nef, Christian Hamm, Pascal Bauer, Christian Troidl, Samuel Sossalla, Sandra Voss, Christoph Liebetrau, Manuel J. Richter, Henning Gall, Werner Seeger, Ardeschir Ghofrani, Athiththan Yogeswaran, Khodr Tello   +15 more
doaj   +3 more sources

Body mass index modifies the major adverse cardiovascular and cerebral events risk of NT-proBNP in patients with acute coronary syndrome [PDF]

Diabetology & Metabolic Syndrome
Background Little is known about the relationship between body mass index (BMI) and the prognostic value of N-terminal pro-B-type natriuretic peptide (NT-proBNP) in patients with acute coronary syndrome (ACS).
Xiaoquan He, Xiaojing Fang, Jiali Wang, Shumei Zhao, Xiaosong Ding, Hui Chen   +5 more
doaj   +2 more sources

The role of NT-proBNP in screening for atrial fibrillation in hypertensive disease [PDF]

International Journal of Cardiology: Heart & Vasculature
Background: Atrial fibrillation (AF) screening should be considered in elderly patients with high risk of stroke, which include individuals with hypertension.
Gina Sado, Katrin Kemp Gudmundsdottir, Carl Bonander, Mattias Ekström, Johan Engdahl, Emma Svennberg   +5 more
doaj   +2 more sources

Clinical value of NT-proBNP, MPO, and NLR combined with echocardiography in prediction of malignant arrhythmia in elderly patients with valvular heart disease [PDF]

Perioperative Medicine
Objective We aimed to probe the clinical value of N-terminus pro-brain natriuretic peptide (NT-proBNP), myeloperoxidase (MPO), and neutrophil lymphocyte ratio (NLR) combined with echocardiography in the prediction of malignant arrhythmias (MA) in elderly
Jianping Liu, Apei Zhou, Meiduan Zheng, Ling Wang, Ping Zeng   +4 more
doaj   +2 more sources

Sendaway capillary NT-proBNP in pulmonary hypertension. [PDF]

BMJ Open Respir Res
BackgroundN-terminal pro-B-type natriuretic peptide (NT-proBNP) is a biomarker of cardiac ventricular wall stress that is incorporated into pulmonary hypertension (PH) risk stratification models. Sendaway sampling may enable patients to perform NT-proBNP tests remotely.
Stubbs HD, Cannon J, Knightbridge E, Durrington C, Roddis C, Gin-Sing W, Massey F, Knight DS, Virsinskaite R, Lordan JL, Sear E, Apple-Pinguel J, Morris E, Johnson MK, Wort SJ.   +14 more
europepmc   +5 more sources

Clinical and Demographic Characteristics of Patients Hospitalized for Decompensated Heart Failure with Extremely High NT-proBNP Levels [PDF]

Diagnostics
Background: NT-proBNP levels with a wide range at admission play both a diagnostic and a prognostic role in patients with HF. The differences regarding the clinical profiles and demography in decompensated HF patients according to NT-proBNP levels at ...
Ruxandra Maria Christodorescu, Daniel Miron Brie, Alina Diduța Brie, Samuel Nistor, Alexandru Tîrziu, Angela Dragomir, Cristian Mornoș, Simona Drăgan, Daniel Duda-Seiman, Adina Pop-Moldovan, Dan Dărăbanțiu   +10 more
doaj   +2 more sources

Machine learning integration of multimodal data identifies key features of circulating NT-proBNP in people without cardiovascular diseases [PDF]

Scientific Reports
N-Terminal Pro-Brain Natriuretic Peptide (NT-proBNP) is important for diagnosing and predicting heart failure or many other diseases. However, few studies have comprehensively assessed the factors correlated with NT-proBNP levels in people with ...
Zhiyuan Ning, Xuanfei Jiang, Huan Huang, Honggang Ma, Ji Luo, Xiangyan Yang, Bing Zhang, Ying Liu   +7 more
doaj   +2 more sources

Periprocedural changes in natriuretic peptide levels and clinical outcome after transcatheter mitral valve repair

ESC Heart Failure, 2021
Aims This multicentre study investigated the association of periprocedural changes in the levels of N‐terminal pro‐B‐type natriuretic peptide (NT‐proBNP) with clinical outcomes after transcatheter edge‐to‐edge mitral valve repair (TMVR).
Tetsu Tanaka, Refik Kavsur, Maximilian Spieker, Christos Iliadis, Clemens Metze, Patrick Horn, Atsushi Sugiura, Malte Kelm, Stephan Baldus, Georg Nickenig, Ralf Westenfeld, Roman Pfister, Marc Ulrich Becher   +12 more
doaj   +1 more source

Effect of body mass index on N-terminal pro-brain natriuretic peptide values in patients with heart failure

The Egyptian Heart Journal, 2023
Background N-terminal pro-B-type natriuretic peptide (NT-proBNP) is a biomarker used for the diagnosis of heart failure. There is a relationship between NT-proBNP levels and body mass index (BMI). The study aimed to explore the impact of BMI on NT-proBNP
Tuan Ha Manh, Duong Do Anh, Tung Le Viet
doaj   +1 more source